OBAI director reports initial share and warrant holdings
TG-17, Inc. director Adam R. Draizin filed an initial statement of beneficial ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TG-17, Inc. director Adam R. Draizin filed an initial statement of beneficial ownership. He reports direct ownership of 3,649 shares of Common Stock. He also directly holds a Series CF-2 Warrant exercisable for 1,294 shares of Common Stock at an exercise price of $3.8643 per share, exercisable from 07/14/2025 and expiring on 02/04/2028. The filing does not show any new purchase or sale, only the holdings as of the event date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Series CF-2 Warrant | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing for OBAI disclose about Adam R. Draizin?
What are the key terms of Adam R. Draizin’s Series CF-2 Warrant in OBAI?
Is the OBAI Form 3 filing reporting any insider buying or selling activity?
What is Adam R. Draizin’s role at TG-17, Inc. (OBAI) according to the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.